1. Home
  2. LEE vs IPSC Comparison

LEE vs IPSC Comparison

Compare LEE & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEE
  • IPSC
  • Stock Information
  • Founded
  • LEE 1890
  • IPSC 2019
  • Country
  • LEE United States
  • IPSC United States
  • Employees
  • LEE N/A
  • IPSC N/A
  • Industry
  • LEE Newspapers/Magazines
  • IPSC Medicinal Chemicals and Botanical Products
  • Sector
  • LEE Consumer Discretionary
  • IPSC Health Care
  • Exchange
  • LEE Nasdaq
  • IPSC Nasdaq
  • Market Cap
  • LEE 52.4M
  • IPSC 49.6M
  • IPO Year
  • LEE N/A
  • IPSC 2021
  • Fundamental
  • Price
  • LEE $6.30
  • IPSC $0.58
  • Analyst Decision
  • LEE
  • IPSC Strong Buy
  • Analyst Count
  • LEE 0
  • IPSC 5
  • Target Price
  • LEE N/A
  • IPSC $3.33
  • AVG Volume (30 Days)
  • LEE 18.0K
  • IPSC 886.3K
  • Earning Date
  • LEE 07-31-2025
  • IPSC 08-07-2025
  • Dividend Yield
  • LEE N/A
  • IPSC N/A
  • EPS Growth
  • LEE N/A
  • IPSC N/A
  • EPS
  • LEE N/A
  • IPSC N/A
  • Revenue
  • LEE $591,094,000.00
  • IPSC $114,898,000.00
  • Revenue This Year
  • LEE N/A
  • IPSC $1,064.82
  • Revenue Next Year
  • LEE N/A
  • IPSC N/A
  • P/E Ratio
  • LEE N/A
  • IPSC N/A
  • Revenue Growth
  • LEE N/A
  • IPSC 8286.72
  • 52 Week Low
  • LEE $6.00
  • IPSC $0.34
  • 52 Week High
  • LEE $19.63
  • IPSC $3.29
  • Technical
  • Relative Strength Index (RSI)
  • LEE 32.43
  • IPSC 52.16
  • Support Level
  • LEE $6.20
  • IPSC $0.58
  • Resistance Level
  • LEE $6.72
  • IPSC $0.66
  • Average True Range (ATR)
  • LEE 0.39
  • IPSC 0.04
  • MACD
  • LEE 0.03
  • IPSC -0.00
  • Stochastic Oscillator
  • LEE 21.00
  • IPSC 41.52

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

Share on Social Networks: